Keeping apples and oranges separate: reassessing clinical trials that use composite end points as their primary outcome.
Chan
Paul S
PS
Nallamothu
Brahmajee K
BK
Hayward
Rodney A
RA
D002318:Cardiovascular Diseases / Q000191:economics / Q000401:mortality* / Q000628:therapy; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data*; D023381:Endpoint Determination; D006801:Humans; D018570:Risk Assessment; D016896:Treatment Outcome